roche
Entity, reached from Hormuz.
- Evidence
- 156 documents · 58 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 12 Jun 2026, last seen 8 Oct 2026
- Measured
- 26% of mentions say something specific about it; the rest only name it
- As of
- 9 Oct 2026
Where this comes from
- STAT News · 2026-10-08 · STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines (opens the source in a new tab)
- Endpoints News · 2026-10-08 · Roche does fourth China deal since August, teaming with Defand on degraders (opens the source in a new tab)
- Fierce Pharma · 2026-10-07 · AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy (opens the source in a new tab)
- Endpoints News · 2026-10-06 · Roche enlists Alector in Parkinson's deal, paying $100M upfront (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-02 · EASD 2026: Roche’s enicepatide shows 22.7% placebo-adjusted weight loss at 48 weeks (opens the source in a new tab)
- Medical Device Network · 2026-10-01 · Roche’s TIB MOLBIOL introduces in vitro newborn screening test kit (opens the source in a new tab)
- Fierce Biotech · 2026-10-01 · Roche launches simultaneous screening test for SMA, SCID and SCD (opens the source in a new tab)
- AllSci News · 2026-09-30 · Roche’s fenebrutinib gets FDA priority review for RMS and PPMS (opens the source in a new tab)
- AllSci News · 2026-09-30 · Chugai resurrects emugrobart in SMA after Roche exits following obesity failure (opens the source in a new tab)
- Endpoints News · 2026-09-30 · #EASD26: Zealand and Roche's amylin works best at middle dose, trails Lilly's (opens the source in a new tab)
1 more on file, counted in the evidence above.
What is claimed about it
- Single source: Reported by one source so far.
- Could not check: We could not count this claim's sources, so we do not say how well it is supported.
- AbbVie, Genmab score first-line DLBCL win for Epkinly, teeing up challenge to Roche's Polivy Could not check · a claim about it
- STAT+: Roche inks drug discovery deal with Chinese biotech, focused on molecular glue medicines Single source · a claim about it
Situations it is named in
Who it moves with
- co-mentioned with fda (51 documents)seen together
- co-mentioned with novartis (43 documents)seen together
- co-mentioned with astrazeneca (34 documents)seen together
- co-mentioned with studie (34 documents)seen together
- co-mentioned with clinical trials (31 documents)seen together
- co-mentioned with eli lilly (30 documents)seen together
- co-mentioned with genentech (28 documents)seen together
- co-mentioned with pfizer (26 documents)seen together